Structural Conditions and Health After Release From Prison
Launched by KAISER PERMANENTE · Aug 3, 2023
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial, titled "Structural Conditions and Health After Release From Prison," is looking into the health challenges faced by individuals who have recently been released from state prison, particularly focusing on heart health. Research shows that people coming out of prison are at a much higher risk of heart-related health issues and death compared to the general population. The study aims to understand the barriers and facilitators that these individuals face in accessing quality healthcare after their release, which is crucial for improving their overall health and preventing serious heart problems.
To participate in this study, individuals must be at least 18 years old, have been recently released from a state prison in the Denver/Aurora area, and be able to understand the study information in English or Spanish. Participants should also plan to stay in the area for at least six months. Those still under correctional supervision or who cannot give consent will not be eligible. If you choose to take part, you can expect to share your experiences regarding healthcare access, which will help researchers better understand how to support individuals transitioning back into the community and improve their health outcomes.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Recenlty released from state prison into the Denver/Aurora Colorado metro area
- • Age 18 and older
- • Ability to understand study procedures in English or Spanish
- • No plans to leave the area for six months
- Exclusion Criteria:
- • On "current inmate" status or still under correctional observation (i.e., under locked confinement part of the day or night)
- • Plans to leave area within six months
- • Unable to consent
About Kaiser Permanente
Kaiser Permanente is a leading integrated health care organization that combines a health plan with a network of hospitals and physicians to provide comprehensive medical services. With a strong commitment to advancing medical research and improving patient care, Kaiser Permanente sponsors clinical trials across various therapeutic areas. The organization emphasizes innovative approaches to health care, leveraging its extensive data and resources to support evidence-based treatments and enhance patient outcomes. Through its rigorous research initiatives, Kaiser Permanente aims to contribute to the advancement of medical knowledge and the development of new therapies that benefit diverse populations.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Aurora, Colorado, United States
Aurora, Colorado, United States
Patients applied
Trial Officials
Stacie Daugherty
Principal Investigator
Kaiser Permanente Institute for Health Research
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported